Wegovy
Wegovy helps people aged 12 and up control their weight. Interestingly, it may also help people control addictive behaviors, too.
Caution
Frequently Abused
Are you struggling with Wegovy?
Uses
What Is Wegovy?
Wegovy is a prescription medication designed for chronic weight management in adults and adolescents aged 12 and older. It is used to help individuals with obesity or those who are overweight and have weight-related medical conditions. Wegovy works by regulating appetite and reducing calorie intake, which leads to weight loss. It is administered as a once-weekly injection and is part of the GLP-1 receptor agonist class of drugs, which mimic a natural hormone in the body to help control hunger and food intake.
Who Makes Wegovy?
Wegovy is manufactured by Novo Nordisk, a Danish pharmaceutical company known for its extensive work in diabetes care and hormone replacement therapies. Novo Nordisk has leveraged its expertise in GLP-1 receptor agonists to develop Wegovy, which has gained approval for its effectiveness in weight management and reducing the risk of cardiovascular events in individuals with obesity or overweight conditions.
How Does Wegovy Work?
Wegovy works by mimicking the action of the GLP-1 hormone, which is naturally produced in the gut. This hormone plays a crucial role in regulating appetite and food intake. By activating GLP-1 receptors in the brain, Wegovy helps to reduce hunger and increase feelings of fullness, leading to lower calorie consumption. Additionally, it slows gastric emptying, which prolongs the sensation of fullness after eating. These combined effects contribute to significant weight loss and improved weight management over time.
Wegovy Side Effects
Wegovy, like any medication, can cause adverse side effects. Here are some common and severe side effects associated with this medication:
Common Side Effects
Nausea
Diarrhea
Vomiting
Constipation
Abdominal pain
Headache
Fatigue
Dizziness
Bloating
Belching
Severe Side Effects
Hypoglycemia (low blood sugar)
Pancreatitis (inflammation of the pancreas)
Gallstones or gallbladder swelling
Increased heart rate
Severe allergic reactions
Risk of thyroid cancer (as indicated by a boxed warning)
If you experience any severe side effects, contact your healthcare provider immediately for guidance and to ensure your safety.
We’re Here To Help You Find Your Way
Would you like more information about mental health or drug addiction? Reach out today.
Warnings
Avoid using this medication if you have multiple endocrine neoplasia type 2 (MEN 2) or a personal or family history of medullary thyroid cancer (MTC).
If you notice symptoms such as swelling or a lump in your neck, difficulty swallowing, a hoarse voice, or shortness of breath, contact your doctor immediately. Research involving rodents has shown that Wegovy and similar medications can lead to thyroid tumors, including thyroid cancer. However, it is unclear whether Wegovy will cause thyroid tumors or a specific type of thyroid cancer known as medullary thyroid carcinoma (MTC) in humans.
Before Taking
Allergies and Contraindications
Do not use Wegovy if you are allergic to it or if you have:
Multiple endocrine neoplasia type 2 (MEN 2), which involves tumors in your glands
A personal or family history of medullary thyroid carcinoma (MTC), a type of thyroid cancer
Diabetic ketoacidosis (seek immediate medical treatment)
Medical History
Inform your doctor if you have ever experienced:
Stomach or intestinal disorders
Pancreatitis
Kidney disease
Eye problems related to diabetes, such as diabetic retinopathy
Depression, suicidal thoughts, or other mental health issues
Animal Studies
In animal studies, semaglutide, the active ingredient in Wegovy, has been linked to thyroid tumors and thyroid cancer. It is not yet known if these effects occur in humans. Discuss your risk with your doctor.
Pregnancy
If you plan to become pregnant, stop using Wegovy at least two months beforehand, as it may harm your baby. Consult your doctor for safer alternatives during this period. Proper diabetes management and appropriate weight gain are crucial during pregnancy. Losing weight while pregnant can be harmful to the unborn baby.
There is a pregnancy exposure registry for women using Wegovy during pregnancy to collect health information about you and your baby. Talk to your doctor about participating in this registry.
Breastfeeding
If you are breastfeeding or planning to breastfeed, inform your healthcare provider. It is unknown if Wegovy passes into breast milk. Discuss the best feeding options for your baby with your healthcare provider while using this medication.
We’ll Lead You to New Heights
Do you have more questions about mental health or drug addiction? Reach out.
Dosages
Wegovy dosages are designed to start low and gradually increase to help minimize gastrointestinal side effects. Below is the recommended dosage schedule for patients aged 12 years and older:
Initial Dose Escalation
Weeks 1 to 4: Begin with 0.25 mg injected subcutaneously once a week.
Weeks 5 to 8: Increase to 0.5 mg injected subcutaneously once a week.
Weeks 9 to 12: Further increase to 1 mg injected subcutaneously once a week.
Weeks 13 to 16: Raise the dose to 1.7 mg injected subcutaneously once a week.
Maintenance Dose
Week 17 and onward: The standard maintenance dose is 2.4 mg injected subcutaneously once a week.
Adjustments for Adults
If the 2.4 mg maintenance dose is not well-tolerated, it can be temporarily reduced to 1.7 mg once a week for up to four weeks. After this period, the dose should be increased back to 2.4 mg once a week. If the patient cannot tolerate the 2.4 mg dose, discontinuation of the medication may be necessary.
Pediatric Patients (12 Years and Older)
For pediatric patients, the recommended maintenance dose is also 2.4 mg injected subcutaneously once a week. If this dose is not tolerated, it can be reduced to 1.7 mg once a week. If the patient cannot tolerate the 1.7 mg dose, discontinuation of Wegovy may be required.
How to Take Wegovy
Instructions for Use
Follow the instructions provided with your prescription and use Wegovy exactly as directed by your healthcare provider. Ensure you receive proper training on how to use this medication before starting.
Injection Method
Wegovy is administered via a pen device, injected subcutaneously into the abdomen, thigh, or upper arm. Avoid injecting into muscles or veins.
Dosage Schedule
Use Wegovy once weekly, on the same day each week, at any time of day. It can be taken with or without food.
Preparing the Injection
Prepare the injection only when ready to use. Contact your pharmacist if the medication appears cloudy, discolored, or contains particles.
Changing Injection Days
If you need to change your weekly injection day, ensure at least two days have passed since your last dose before starting the new schedule.
Rotating Injection Sites
Rotate the injection site with each dose. You can use the same body area but choose a different spot each time. Avoid areas that are tender, bruised, red, or hard, and steer clear of scars or stretch marks.
Using the Pen
The Wegovy pen is single-use, with a pre-set dose. The needle is covered and not visible. Remove the pen cap only when ready to inject. Avoid touching or pressing the needle cover to prevent injury.
Administering the Injection
Press the pen firmly against the skin and hold until the yellow bar stops moving. If the yellow bar does not move, press the pen more firmly. You will hear two clicks: the first indicates the injection has started, and the second means it is ongoing. Do not remove the pen until the yellow bar stops moving to ensure you receive the full dose.
Post-Injection
If the yellow bar does not move or stops during the injection, contact your healthcare provider. The needle cover will lock once the pen is removed from the skin, preventing reuse. Dispose of the used pen in an FDA-cleared sharps container immediately. Do not dispose of it in household trash.
Special Considerations
Individuals who are blind or have vision problems should seek assistance from someone trained to use the pen.
What If I Miss a Dose?
If you miss a dose of Wegovy, take it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed one.
Avoid taking extra doses to compensate for the missed one, as this can lead to an overdose. Always maintain the prescribed dosing schedule for optimal effectiveness.
How Long Does It Take Wegovy to Work?
Wegovy typically begins to show its effects within a few weeks of starting treatment. Most users notice a decrease in appetite within the first few days, and significant weight loss can be observed by the four-week mark. On average, individuals may lose around 2% of their body weight in the first month. As the dosage is gradually increased to the maintenance level, more substantial weight loss is expected over the following months, with many users achieving around 15% weight loss after 17 months of consistent use. Results can vary based on individual factors and adherence to a healthy lifestyle.
Interactions
When taking Wegovy (semaglutide), it’s crucial to be aware of potential interactions with other drugs, foods, and substances that could impact its efficacy. Understanding these interactions can help you manage your treatment more effectively and avoid adverse effects.
Drug Interactions
Wegovy can interact with a variety of medications, which may alter its effectiveness or increase the risk of side effects. Some of the notable drug interactions include:
Antibiotics: Certain antibiotics, such as ciprofloxacin and clarithromycin, can increase the risk of low blood sugar when taken with Wegovy.
Antidepressants: Medications like fluoxetine and tranylcypromine may also elevate the risk of hypoglycemia.
Blood Pressure Medications: ACE inhibitors (e.g., lisinopril) and angiotensin II receptor blockers (e.g., losartan) can interact with Wegovy, potentially leading to low blood sugar levels.
Diabetes Medications: Insulin, sulfonylureas, and meglitinides can increase the risk of hypoglycemia when used in combination with Wegovy.
Other GLP-1 Receptor Agonists: Using other glucagon-like peptide-1 (GLP-1) medications, such as dulaglutide, alongside Wegovy can heighten the risk of side effects.
Food and Alcohol Interactions
Certain foods and alcohol can also interact with Wegovy, affecting its absorption and efficacy:
High-Fat Meals: Consuming high-fat meals may delay the absorption of Wegovy, potentially reducing its effectiveness.
Alcohol: Drinking alcohol while on Wegovy can increase the risk of hypoglycemia, especially if you have diabetes.
Other Substances
In addition to medications and foods, other substances can interact with Wegovy:
Supplements: Some dietary supplements, particularly those affecting blood sugar levels, can interact with Wegovy. It’s essential to discuss any supplements you’re taking with your healthcare provider.
Herbal Products: Certain herbal products may also impact the effectiveness of Wegovy. Always consult your doctor before starting any new herbal treatments.
By being aware of these potential interactions, you can better manage your treatment with Wegovy and ensure its maximum efficacy. Always consult your healthcare provider before starting or stopping any medications, supplements, or dietary changes.
We’re Here To Help You Find Your Way
Do you need advice about mental health or drug addiction? Reach out today.
Overdose Potential
The potential for overdose with Wegovy (semaglutide) is a serious concern that requires immediate medical attention. Symptoms of an overdose may include severe nausea, vomiting, and hypoglycemia, which can lead to dizziness, confusion, and even loss of consciousness. In extreme cases, an overdose can result in significant dehydration and electrolyte imbalances, necessitating urgent medical intervention.
If you suspect an overdose, seek urgent medical support. To prevent overdose, always adhere to the prescribed dosage and consult your healthcare provider before making any changes to your medication regimen. Proper storage and handling of Wegovy can also help minimize the risk of accidental overdose.
Addiction Treatment
Is Wegovy Addictive?
Wegovy is not considered to be addictive. Primarily used for weight management and type 2 diabetes, semaglutide has actually shown potential in reducing addictive behaviors by influencing the brain’s reward pathways. However, it’s important to note that Wegovy is not approved by the FDA for treating addiction, and its effectiveness in this area is still being explored through clinical trials.
We’re Here To Help You Find Your Way
If you or a loved one is struggling with addiction, there is hope. Our team can guide you on your journey to recovery. Call us today.
FAQ
Frequently Asked Questions
Wegovy is a prescription medication used for chronic weight management in adults and adolescents with obesity or overweight conditions. It contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone to regulate appetite and calorie intake. By reducing hunger and increasing feelings of fullness, Wegovy helps individuals lose weight and maintain weight loss when combined with a reduced-calorie diet and increased physical activity.
Wegovy typically starts at a dose of 0.25 mg once a week for the first month, gradually increasing to the maintenance dose of 2.4 mg per week over several months. This gradual escalation helps minimize side effects like nausea. While some individuals may notice appetite suppression and initial weight loss within the first few weeks, significant weight loss usually becomes more apparent after reaching the higher doses.
On average, you may see a weight reduction of about 5% within the first three months of treatment. In a cohort study of 175 patients with overweight or obesity, the total body weight loss percentages achieved were 5.9% at 3 months and 10.9% at 6 months. Other studies have shown that individuals taking Wegovy can lose an average of 15% of their body weight over a period of 68 weeks. The amount of weight loss varies, with some people losing more and others less, depending on factors like adherence to the medication, diet, and exercise regimen.
There are several reasons why you might not be losing weight on Wegovy, including not following a reduced-calorie diet, insufficient physical activity, or not taking the medication as prescribed. Additionally, individual metabolic differences and underlying health conditions can affect weight loss outcomes. If you are not seeing the expected results, it is important to consult with your healthcare provider to adjust your treatment plan.
Nausea is a common side effect when starting Wegovy, typically occurring during the initial dose escalation phase. For most people, nausea tends to subside within a few days to a few weeks as the body adjusts to the medication. To manage nausea, it is recommended to eat smaller, more frequent meals and avoid high-fat foods. If nausea persists, consult your healthcare provider for further guidance.